Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities,
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-23 7:00 AM EDT | Phio Pharmaceuticals Corp.
Trenchant Technologies Capital Corp. Completes Unwinding of Previous Limitless Quantum Acquisition and Corporate Updates
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Trenchant Technologies Capital Corp. (CSE: AITT) (OTCQB: AITTF) ("Trenchant" or the "Company") announces that it has completed the unwinding of the Company's acquisition of Limitless Quantum Computing Solutions Inc. ("Limitless Quantum") (collectively, the "Unwinding Transaction"), as previously announced on April 8, 2026. The Compan
Technologies, Services bancaires / financiers, Biotechnologies, Soins de santé et hôpitaux
2026-04-22 8:30 AM EDT | Trenchant Technologies Capital Corp.
Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year
Winter Park, Florida--(Newsfile Corp. - April 22, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and biologic products through its Adia Med clinics and Adia Labs division, today announced that it is actively looking to acquire a larger property to expand its flagship Adia Med clinic in Winter Park, Florida. This strategic initiative aims to significantly increase the clinic's size and capacity, enabling expanded patient access to advanced r
Soins de santé et hôpitaux, Santé
2026-04-22 8:00 AM EDT | Adia Nutrition Inc.
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that all 56 patients implanted and enrolled in its pivotal clinical trial evaluating the fully implanted Acclaim® cochlear implant have been through their "Activation Visits," when a patient's device is initially turned on for the first time. "The conclusio
Biotechnologies, Soins de santé et hôpitaux
2026-04-22 8:00 AM EDT | Envoy Medical, Inc.
HEALWELL AI Appoints Brad Porter to Board of Directors
Toronto, Ontario--(Newsfile Corp. - April 22, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF)
Technologies, Soins de santé et hôpitaux
2026-04-22 3:15 AM EDT | HEALWELL AI
TelyRx Announces Year-End 2025 Financial Results
Clearwater, Florida--(Newsfile Corp. - April 21, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today filed audited financial statements for TelyRx, Inc., its wholly-owned subsidiary and reverse takeover acquirer, on SEDAR+ for the year ended December 31, 2025. All dollar amounts are expressed in U.S. dollars. Highlights for the Year and Fourth Quarter of 2025
Soins de santé et hôpitaux, Santé
2026-04-21 4:49 PM EDT | TelyRx
WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026
WELL Canada delivered a record ~1.27 million patient visits(1) in Q1-2026, representing 33% year-over-year growth and 13% organic growth, reflecting broad-based strength across its national network. Primary Care Adjusted EBITDA(2) margins expanded to approximately 8% in Q1-2026 on a preliminary basis, up approximately 200 basis points from 6% in Q1-2025, driven by WELL's clinic transformation program and re
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-04-21 7:00 AM EDT | WELL Health Technologies Corp.
LevelJump Closes Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce that, further to its news release of April 7, 2026, it has closed, effective as of April 16, 2026, a non-brokered private placement (the "Offering") through the issuance of 14,380,000 common shares (the "Offered Shares") at a price of C$0.05 per Offered Share in the capital of the Company for gross proceeds of C$719,000. All sec
Soins de santé et hôpitaux, Santé
2026-04-20 12:12 PM EDT | LevelJump Healthcare Corp.
Richards Group Inc. Announces April 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today its cash dividend for the month ended April 30, 2026 of Cdn$0.11 per share. This dividend will be to shareholders of record at the close of business on April 30, 2026 and will be payable on May 14, 2026. Shareholders who are non-residents of Canada may be required to pay all withholding taxes payable in respect of any dividends of income by the Company, whether such dividends
Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques, Pharmaceutique
2026-04-20 10:24 AM EDT | Richards Group Inc.
All Star Health Brands (ALST) Explores Acquisition of Resort Property in Sanremo to Expand Future Soccer Programs
Toronto, Ontario--(Newsfile Corp. - April 17, 2026) - ALST (OTCID: ALST) today announced it is actively exploring the potential acquisition of a resort property in Sanremo, Italy, as part of a strategic initiative to expand its long-term investment in soccer development programs. The proposed acquisition reflects ALST's commitment to fostering athletic excellence, youth development, and international sports collaboration. The Sanremo location, known for its coastal setting and establish
Soins de santé et hôpitaux, Commerce de détail, Santé
2026-04-17 8:00 AM EDT | Allstar Health Brands, Inc.
CareRx Welcomes Stability in Long-Term Care Pharmacy Funding in Ontario
Toronto, Ontario--(Newsfile Corp. - April 16, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, welcomes the Ontario Ministry of Health's recent Executive Officer Notice confirming the current annual pharmacy long-term care capitation rate of $1,500 per licensed bed will be maintained and that the Ministry will not implement previously scheduled red
2026-04-16 4:30 PM EDT | CareRx Corporation
medmix' Shareholders Approve All Proposals at Annual General Meeting 2026
medmix AG Neuhofstrasse 20 CH-6430 Baar communications@medmix.com www.medmix.swiss DOWNLOAD
Technologies, Construction / bâtiments, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-04-16 8:37 AM EDT | medmix AG
Envoy Medical Appoints Chas McKhann to Board of Directors
White Bear Lake, Minnesota--(Newsfile Corp. - April 16, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced the appointment of Chas McKhann, a seasoned medical technology executive with documented success, to its Board of Directors. Mr. McKhann is a well-known and respected med tech leader with extensive experience cre
Biotechnologies, Soins de santé et hôpitaux
2026-04-16 8:00 AM EDT | Envoy Medical, Inc.
Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
Calgary, Alberta--(Newsfile Corp. - April 16, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announces the revocation, effective April 15, 2026, of a management cease trade order ("MCTO") issued by the Alberta Securities Commission (the "ASC") on April 1, 2026 at the request of the Company. The Company filed its audited financial statements, management's discussion & analysis, certifications of annual filings, and annual information form for the year
Technologies, Biotechnologies, Soins de santé et hôpitaux
2026-04-16 7:15 AM EDT | Resverlogix Corp.
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
Ontario and Chicago, Illinois--(Newsfile Corp. - April 15, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today provided an operational business update on the ongoing commercialization of GRAFAPEX™ (treosulfan) for Injection in the United States and on certain recent capital allocation and capital structure developments and announced company management's participation in two upcoming investor conferences. All dollar amounts in this news release are in US dollars unle
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-15 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Patient Safety Must Remain the Foundation of Scope of Practice Decisions in Canada
Ottawa, Ontario--(Newsfile Corp. - April 15, 2026) - As scope of practice expansion is actively being considered across Canada, the Canadian Ophthalmological Society (COS) is emphasizing that patient safety must remain the central and non-negotiable principle guiding any changes to healthcare delivery. While COS supports innovation and system modernization, it is deeply concerned that several proposed changes would expand independent clinical authority to non-physician providers without
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-15 12:05 PM EDT | Canadian Ophthalmological Society (COS)
La sécurité des patients doit demeurer le fondement des décisions relatives au champ de pratique au Canada
Ottawa, Ontario--(Newsfile Corp. - 15 avril 2026) - Alors que l'élargissement des champs de pratique est activement envisagé à travers le Canada, la Société canadienne d'ophtalmologie (SCO) rappelle que la sécurité des patients doit demeurer le principe central et non négociable guidant toute évolution de la prestation des soins de santé. Bien que la SCO appuie l'innovation et la modernisation du système, elle demeure profondém
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-04-15 12:05 PM EDT | Canadian Ophthalmological Society (COS)
Scryb Approves Proposed Name Change and Grant of Stock Options
Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - Scryb Inc. (CSE: SCYB) ("Scryb'' or the "Company"), is pleased to announce that it intends to complete its corporate name change to NorthPalm Capital Corp., marking the next phase in the Company's evolution and reflecting a renewed strategic focus on shareholder value creation and disciplined growth. Under the new NorthPalm Capital, the Company plans to focus on timing, execution, and high-growth opportunities, suppo
Biotechnologies, Soins de santé et hôpitaux, Santé
2026-04-15 11:34 AM EDT | Scryb Inc.
Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model
Winter Park, Florida--(Newsfile Corp. - April 15, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine, stem cell therapies, and biologic products, today announced that it is in the process of changing its corporate name to Adia Med, Inc. The name change reflects the company's evolving business model, which has shifted significantly toward advanced medical treatments and biologics. Adia now operates through key divisions inclu
Soins de santé et hôpitaux, Santé
2026-04-15 8:30 AM EDT | Adia Nutrition Inc.
CareRx Corporation Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21-22, 2026, at the Metro Toronto Convention Centre. Puneet Khanna, President & Chief Executive Officer and Suzanne Brand, Ch
2026-04-15 7:30 AM EDT | CareRx Corporation